StockData
Palisade Bio, Inc. logo

Palisade Bio, Inc. (PALI) stock

PALINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$0.84−0.09 (-9.24%)

Close on Nov 20, 2026Market cap $146.37MP/E –Yield –

Palisade Bio free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Palisade Bio's free cash flow for the twelve months ending Dec 31, 2024 was -$12.19M. For fiscal 2024 it was -$12.19M. The highest annual figure on record is -$4.77M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$12.19M–
FY2023Dec 31, 2023-$11.14M–
FY2022Dec 31, 2022-$13.37M–
FY2021Dec 31, 2021-$14.77M–
FY2020Dec 31, 2020-$4.77M–
FY2018Dec 31, 2018-$7.69M–
FY2017Dec 31, 2017-$13.43M–
FY2016Dec 31, 2016-$15.71M–
FY2015Dec 31, 2015-$19.11M–
FY2014Dec 31, 2014-$11.91M–
FY2013Dec 31, 2013-$10.72M–
FY2012Dec 31, 2012-$8.52M–
FY2011Dec 31, 2011-$8.29M–
FY2010Dec 31, 2010-$10.06M–
FY2009Dec 31, 2009-$5.23M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024-$2.38M–
Q3 FY2024Sep 30, 2024-$3.13M–
Q4 FY2023Dec 31, 2023-$2.75M–
Q3 FY2023Sep 30, 2023-$2.66M–
Q4 FY2022Dec 31, 2022-$3.32M–
Q3 FY2022Sep 30, 2022-$3.04M–
Q4 FY2021Dec 31, 2021-$3.06M–
Q3 FY2021Sep 30, 2021-$2.75M–
Q4 FY2020Dec 31, 2020-$1.55M–
Q3 FY2020Sep 30, 2020-$868.00K–
Q4 FY2017Dec 31, 2017-$2.29M–
Q3 FY2017Sep 30, 2017-$3.32M–
Q4 FY2016Dec 31, 2016-$4.08M–
Q3 FY2016Sep 30, 2016-$4.48M–

More Palisade Bio figures

See a number that looks wrong?